Podcasts about numinus

Send us a textMeditation as a practice, a life path, or a mindset is central to many ancient wisdom traditions and modern psychotherapies. It's also a useful tool for preparing for, navigating, and integrating psychedelic experiences. In today's episode of the Psychedelic Therapy Frontiers podcast, we explore the definitions, components, and applications of meditation and mindfulness for psychedelic therapy and everyday life. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn today's episode of the Psychedelic Therapy Frontiers podcast, we're talking about a few counterintuitive ideas or paradoxes that one might encounter on their personal growth or healing journey. Due to their paradoxical nature, these ideas can be difficult to accept. Ideas like, “only when I accept myself as I am do I then have the freedom to change” can be confusing at first glance. Reid and I attempt to clarify a few of the most common and important paradoxes in today's episode and we hope you find it useful. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn today's episode of the Psychedelic Therapy Frontiers, the podcast, Dr. Steve Thayer and Dr. Reid Robison discuss boundaries. They explore the importance and challenges of setting healthy boundaries, different categories of boundary-setting, clarifying personal values, protecting your time and energy, what leads to unhealthy boundaries, good professional boundaries for helping professionals, and much more.*This episode originally aired 4/26/24Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trialsLearn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.comFollow us on Instagram:https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn today's episode of the Psychedelic Therapy Frontiers podcast, we're talking about unfinished business. Now I don't mean “unfinished business” in the hyper-aggressive revenge film kind of way. No, we're talking about unresolved emotions, memories, or conflicts from the past that intrude on the present causing us to wonder why we keep doing, thinking, and/or feeling things even though it doesn't serve us. We explore why this happens and what to do about it from a variety of therapeutic perspectives including Gestalt, psychoanalytic, IFS, CBT, and psychedelic-assisted. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Healing is often presented as a straightforward path: visit the doctor, take the prescribed medication, follow the treatment plan. But what if true healing is far more complex—deeply rooted in both the mind and body?In this episode, I sit down with Payton Nyquvest, founder and CEO of Numinus, to explore the intersection of psychedelic therapy, trauma healing, and the ancient wisdom that modern medicine often overlooks.We'll discuss how psychedelics influence neuroplasticity and memory processing, why they are not a shortcut to healing but rather a tool for deeper self-awareness, and the crucial distinction between therapeutic and recreational use. Payton also breaks down the mechanisms behind trauma storage in the body and how intentional psychedelic-assisted therapy may help unlock profound healing.As a leader in the integration of psychedelics into healthcare, Payton brings a grounded, evidence-based perspective to a topic that is often misunderstood. Whether you're curious about the science behind these therapies or simply seeking a deeper understanding of how to reconnect with yourself, this conversation offers invaluable insights.We Also Discuss:(00:00) Psychedelics and Ancient Wellness Integration(06:43) Daily Wellness Practices and Psychedelic Therapy(13:18) Therapeutic Potential of Psychedelic Therapy(21:25) Psychedelic Therapy(28:07) Healing Through Psychedelic Experiences(40:58) Psychedelic Therapy and the Science(50:35) Transformative Potential of Psychedelic Therapy(01:03:33) DMT Healing Ceremonies in TulumThank you to our sponsorFatty 15: Fatty15 is on a mission to optimize your C15:0 levels and help you live healthier, longer. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/MONA and using code MONA at checkout.Keywords:Psychedelics, Ancient Wisdom, Modern Healthcare, Numinous Health, Transformative Journey, Meditation, Breath Work, Nutrition, Resilience, Mental Health, Therapeutic Potential, Ketamine-Assisted Therapy, Brain, Default Mode Network, Self-Awareness, Healing, Microdosing, Education, Regulation, Respect, Holistic Healthcare, Ancient Practices, Modern Science, Personal Growth, Decriminalization, Clinical Trials, MDMA, PTSD, Depression, Anxiety, Personalized Treatment, Chronic Pain, Neuroplasticity, MAPS, Drug Approval, Health Optimization, Organic Food, Clean Water, Microdosing Industry, Postpartum Depression, Mental Health Care, Personalized Protocols, Curative Approach, Mental Health Diagnoses, Rapid Transformation, DMT, Tulum, Healing Experience, Emotional Release, Trauma, Pain, Sobbing, Nature, Beauty, Healing Energies, Personal Growth, Emotional HealingLearn more about Mona SharmaWebsite: www.monasharma.comInstagram: @monasharmaSHOP NOW: Cymbiotika.com/MonasharmaLearn More about Payton NyquvestWebsite: https://numinus.com/Instagram: https://www.instagram.com/numinushealth/#

Send us a textDo you ever feel like something is wrong with you? Like if you were just able to fix the way you think, feel, or behave then you would finally enjoy peace, connection, and freedom? Perhaps you've even gone to therapy with this intention and worked hard to heal traumas, challenge negative thinking, and establish healthier habits. But what if you aren't actually broken? What if you are already whole and free? In today's episode of the Psychedelic Therapy Frontiers podcast, we explore Eastern philosophies of non-dual awareness, resistance, attachment, surrender, and freedom and discuss how they can be integrated with modern Western psychotherapy. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textSigmund Freud said that dreams are the royal road to a knowledge of the unconscious activities of the mind. In today's episode of the Psychedelic Therapy Frontiers podcast, we explore this royal road as we discuss the nature of dreams, the neurophysiology of the dreaming brain, the therapeutic utility of dream interpretation, nightmare rescripting, lucid dreaming, and the parallels between dreams states and and the altered states occasioned by psychedelics.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textHave you ever been accused of being insecure? It's something, if we're being honest with ourselves, nearly all of us struggle with. I'm not smart enough, attractive enough, rich enough, successful enough. It seems like there are an infinite number of rulers that prove how poorly we measure up. But where do these insecurities come from? Why do we often feel so inadequate? And perhaps most importantly, how can we overcome our insecurities? In today's episode of the Psychedelic Therapy Frontiers podcast, we try to answer these questions and more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textWhat is consciousness? Is it unique to humans? Is a bat, a tree, or an AI agent conscious? What does it mean for something to be subconscious or unconscious? What does altering consciousness with psychedelic compounds teach us about its nature? How does understanding consciousness help us improve our mental health? In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss these questions and more as we explore the nature of conscious awareness.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textThe human mind is a meaning-making machine. It does its best to make sense out of the constant barrage of information flooding it moment to moment. One of the ways your mind does this is by creating and using filters. These filters go by many names: cognitive bias, heuristics, core beliefs, values, narratives, prejudice, etc. In today's episode of the Psychedelic Therapy Frontiers podcast, we explore how these filters work for us and against us and discuss how you can become the author of your own internal story.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss adult development. That's right, folks. Developmental stages aren't just for the kids. Reid and Steve explore different theories on adult development, particularly Ken Wilber's integral theory and Maslow's hierarchy of needs. They talk a bit about their own approaches to personal development and how they help clients on this journey. They also discuss the phenomenon of the so-called midlife crisis, waking up vs growing up, how to zero in on your values and live life accordingly, and much more. *This episode originally aired 11/28/23Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textDo you have one of those fancy wearable devices that tracks your sleep? How reliable are those things? Could they help detect a serious sleep disorder like sleep apnea? How detrimental is sleep apnea on physical and mental health? What are the latest treatment innovations for sleep apnea? Can psychedelics help people with personality disorders? Could 5-MeO-DMT help reduce excessive alcohol consumption? Could LSD be used to treat anxiety? What happens when you let people self-regulate a DMT dose through an IV? In today's episode of the Psychedelic Therapy Frontiers podcast, we share data from a number of studies that seek to answer these questions. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIf you take any beginner's class in economics or finance you undoubtedly learn about how investments grow over time via compound interest. But what if we apply this concept of investment and compounding growth to personal development? In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss a variety of approaches to personal growth, healing, and development using the metaphor of investment and compounding growth. We cover the “imperfectionist” approach, treating the mind like a garden, how to think about failures, dealing with discomfort, the importance of rest, clarifying values, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textWhen we describe artists we typically describe them in terms of their medium: a musician, a scuplter, a painter, a poet, etc. But what does it really mean to be an artist or, for that matter, to be creative? Can you be an artist without a medium? How do we think about or describe the creative act? What might life look like if we were to view it as a work of art?In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss these questions and more with special guest, Haymitch St. Stephen. Haymitch is an artist and contemplative who is dedicated to helping others cultivate creativity as a spiritual practice. One of his recent creative projects that we discuss in this episode is his book, Friend of the Devil: A story of Mental Health, Mistakes, and Self-Forgiveness. If listening to this episode leaves you hungry for more Haymitch, you can find him at his website stillpoint.life where you can also check out the “Nature of Creation” retreat he's running on Feb 15th.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.https://www.stillpoint.life/event-details/the-nature-of-creation-1Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textHow relevant are the teachings of ancient philosophers for modern problems? Marcus Arelius didn't have social media. The Buddha never got stuck in bumper-to-bumper traffic. At first glance the stressors of modern life seem so different from what humans had to deal with a few hundred or especially a few thousand years ago.In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss how and why the principles taught by ancient philosophers are relevant and helpful for addressing our uniquely modern problems. We also explore a few modern philosophies and discuss how philosophy and the practice of psychotherapy overlap. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textLast episode we talked about taking time as a new year approaches to reflect on the previous year. In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss how to make new year's resolutions that really matter to you. We explore why we struggle to accomplish new year's resolutions, the difference between goals and values, the importance of self-compassion when trying to make changes, learning from life's challenges, avoiding toxic positivity, actionable systems for habit change, and much more.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus Network and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a text2024 is coming to a close. Before we give too much thought to resolutions and intentions for the new year, it can be helpful to reflect on the past year. In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss what can be gleaned from a yearly reflection practice, review some notable developments in the psychedelic therapy space, and do some reflecting ourselves. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Disclaimer: The content of this podcast does not constitute medical advice or mental health treatment. Consult with a medical/mental health professional if you believe you are in need of mental health treatment.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textReid has recently returned from the Ram Das Legacy Retreat in Maui run by the Love Serve Remember Foundation. In today's episode of the Psychedelic Therapy Frontiers podcast we sat down for a trip report with Reid's brother, Jeremy Robison, and our friend, John Patterson, who also attended the retreat. We discuss the theme of the retreat (“grist for the mill”), their motives for going, their experiences at the retreat, the healing power of music, aversions to gurus, how life's challenges can become our guru, the life of Ram Dass, psychedelic experiences without ingesting substances, psychospiritual journeys, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.You can learn more about Jeremy's latest project I Am Sound at https://iamsound.one/.You can learn more about John's therapy practice at https://www.choiceholisticrecovery.com/ Check out John's music on Spotify at https://open.spotify.com/artist/7jpG13xu7wCcAixo3DuOvDhttps://on.soundcloud.com/r4UBWVTpYzJt4MkK8Disclaimer: The content of this podcast does not constitute medical advice or mental health treatment. Consult with a medical/mental health professional if you believe you are in need of mental health treatment.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn today's episode of the Psychedelic Therapy Frontiers podcast we're exploring legacy (or sometimes called ancestral) burdens and gifts. This is the idea that beliefs, interpersonal patterns, narratives, emotions, unresolved trauma, and/or pain from previous generations can be passed down to descendants, influencing their psychological, emotional, and even physical well-being. We discuss how this is possible from psychological, developmental, psychospiritual, and biological perspectives; how one might heal the burdens; and how one might benefit from the gifts. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIf an artificial intelligence (AI) therapist was available, would you use it? Could an AI program replace your therapist? What are the potential opportunities and risks of using AI for help with your mental health? What might the future hold as this technology advances? In today's episode of the Psychedelic Therapy Frontiers podcast we explore the revolutionary, exciting, and sometimes frightening world of AI in mental health care.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Today, The Frontier Psychatrists welcomes back my friend Ben Spielberg. He's been a reader for a long time and has contributed to the newsletter in the past. It was on Clinical Trial design, a perennial favorite around these parts.With only light edits, what follows is his work, narrated by me, for the Audio Version.I would invite you to the live class today on working as an out-of-network provider, but it sold out last night, so you'll have to wait for the next one. My prior article on Spravato is available here.The year is 2024. OpenAI has just launched its latest update to ChatGPT, promising more natural and less artificial-sounding language. Donald Trump has won the nomination for President of the United States. Another chain of ketamine clinics has engaged in a corporate reorganization. There is conflict in the Middle East. Are we sure that we're not living Groundhog's Day?I am the founder of Bespoke Treatment, an integrative mental health facility with multiple locations that has at times been referred to as a "ketamine clinic." I have also seen countless so-called "ketamine clinics" sell for pennies on the dollar and go bankrupt seemingly overnight. In this case, Numinus, a company that was publicly traded in Canada and owned a number of psychiatric clinics specializing in ketamine in the US and Canada, has sold its clinics to Stella (a company that has stealthily become one of the larger mental health providers in the country and is the first to bring the awesome SGB treatment to scale). It's not the first time this has happened. It's not the second, nor the third, nor even the fourth time this has happened. But yet, the common consensus is that ketamine clinics are a cheap, easy business with recurring revenue. So, what gives?Figure 1. A reddit user asking anesthesiologists if they should start a ketamine or Botox clinic for easy cash on the side. Does this make you feel gross? Should it?The Ketamine Clinic Model 101The most basic outline for a ketamine clinic is as follows: a provider rents an office space with, on average, five or so exam rooms. They buy equipment for infusions like a pump, catheter, needles, and syringes. They buy some comfortable recliner chairs. They hire a receptionist to answer phones, field patient questions, charge credit cards, and handle medical record requests. They hire a nurse to insert the IV, monitor vital signs, check blood pressure, juggle multiple patients at once, and make sure the ketamine is flowing into patients' veins unencumbered. Two SKUs are typically offered: ketamine infusions for mood, which last approximately 40 minutes, and ketamine infusions for pain, which last for up to 4 hours. Zofran is offered for nausea, and some clinics have fun add-ons like magnesium or NAD. An average mood infusion costs around $400-$500 in a medium cost-of-living area, while mood-infusions can run up to $700 in a higher cost-of-living area. Some clinics offer package discounts if patients buy six or more upfront, which helps with cash flow for the clinic (cash now is better than cash later, of course).A Note on Scope of PracticeThe first wave of ketamine clinics was started mainly by providers who were not mental health specialists. Instead, they were owned by anesthesiologists, ER physicians, and sometimes CRNAs. These providers were especially experienced with ketamine in hospital settings, as well as setting up infusions. Psychiatrists, on the other hand, do not usually order infusions in outpatient settings, and very few had actual hands-on experience with ketamine in practice. That being said, there are a number of variations to the model above: psychiatrist-owned ketamine clinics would often prefer to use intramuscular injections in lieu of infusions, but 2-3 injections would have to be given during a single session for mood and pain sessions were out of the question. Other ways to save costs might include having an EMT do the actual injections (this is highly state-dependent), asking nurses or MAs to work the front desk, or working a full-time regular doctor job. In contrast, your nurses run the actual ketamine services via standing orders, a written document that details routine and emergent instructions for the clinic.Some clinics offer full evaluations prior to rendering treatment, but many offer a simple brief screening on the phone to check for contraindications before scheduling a patient for their first session. The clinics owned by psychiatrists have historically been a bit more thorough in terms of the initial psychiatric evaluations, given that they can actually perform initial psychiatric evaluations within their respective scope of practice. Sometimes clinics may have therapists on-site who can render ketamine assisted therapy (meaning, therapy occurring concurrently) for an additional $100-$300. Otherwise, there is not much decision-making that goes on— other than deciding on medication dosages. Most infusions start off at .5mg/kg of body weight, which is by far the most evidence-based dosage. In practice, most clinics increase dosage every session because even though ketamine is considered to be a weight-based medicine for anesthesia, there is thought to be a “sweet spot” of dosage for everyone, if one can imagine an inverted U shape curved, where the ideal dosage for each patient is at the tippity-top of the inversion. Dosage increases are highly variable depending on the clinic: some have a maximum dosage, some will only increase a certain percentage, and some may even use standardized increments (e.g., only offering dosages in increments of 50mg). A typical series of infusions is 6-8 over 3-4 weeks, followed by boosters as needed.Fool's GoldAt first glance, the business model seems fantastic. As a cash business, there are no AR issues, no third party billing companies to deal with, and no prior authorizations to fight over. Sure, the cost is high, but it's not that high compared to many other healthcare services. Since the benefits fade over time, a ketamine clinic has built-in recurring revenue from patients every week, month, quarter, or year – it's like a subscription business! Ketamine is trendy and sexy; TV shows like White Lotus mention it, and ravers from the 90's recall it with great fondness. Unlike SSRIs and psychotherapy, ketamine works for depression fast. It's amongst the fastest treatments for depression that we have today, and there are a lot of depressed people. It can help someone out of debilitating depression in 40 minutes. It has none of the un-sexy side effects of SSRIs like sexual dysfunction, gastrointestinal discomfort, or uncontrollable sweating. Instead, it has sexy side effects: euphoria, hallucinations, and feelings of unity with the universe. Also, unlike SSRIs, it helps most people who try it. It really is an amazing treatment, and I often feel grateful that my clinic is able to offer it to patients in needFigure 2. Most business-savvy reddit user.Supply and Demand… or SomethingMood disorders disproportionately affect individuals who are of lower socioeconomic status compared to individuals with a lot of disposable income. Of course, wealthier individuals are no more immune to mental health disorders than anyone else, but the main target market that benefits most from ketamine just do not have the means to afford it. They don't have $3,000 to burn on yet another treatment that may or may not work. Often, the patients who could really use a series of ketamine infusions cannot scrounge enough money for a single infusion, let alone a whole series and prn boosters. However, there should be enough depressed people with cash to throw around out there… right?Wait, Isn't That A Horse Tranquilizer?Of course, ketamine clinics can find more patients via marketing and advertising. However, I've found that many medical doctors who see this population, like primary care providers, are not up to date with the research. When I first launched my company, I used to go door-to-door to medical buildings in Santa Monica with cookies to speak with them about advancements in interventional psychiatry. I cannot count the number of times that I was laughed out of each office; referring providers are risk-averse, and the perception of ketamine has traditionally been poor. Medical doctors would exclaim, “Of course people feel better; you're getting them high,” and lament that I was administering a drug thought to be highly addictive. Psychotherapists, who would also be fantastic referral partners, generally refer to psychiatry, but it's less common for them to refer to specific treatments. Nowadays, psychotherapists who are particularly invested in ketamine can sign up with venture-backed companies like Journey Clinical and render their own ketamine-assisted psychotherapy with some prescriber supervision. The issue is that despite the media attention, people with depression don't read innovative health newsletters, nor do they review papers in scientific journals. They rely on information from their psychiatrists, medication management providers, and psychotherapists. If they are not told that this is an option for them, they won't hear about it without ad spend. Oh yeah, and there is a major issue with ad spend: the word ketamine itself is a restricted drug term, and legitimate clinics routinely get banned from Google and Meta for mentioning it, which makes digital advertising more difficult than it would be for any other legitimate service.The Matthew Perry EffectKetamine is very desirable for some patients (unfortunately, sometimes the patients who want it most are frankly the worst candidates for it), but I'd wager that the majority of patients who need it are kind of scared of it. They want to feel good, they want relief from depression and trauma, but it's a weird thing to do a drug that is a horse tranquilizer and also an anesthetic in a reclining chair in a medical office that tricks your brain into feeling like you're dead for a little bit. It's kind of far off from acupuncture and more traditional alternative medicine. There is certainly a non-zero addictive potential that needs to be carefully weighed, it's not a particularly comfortable experience for many patients—especially those with a history of trauma—even if it helps after the experience is over. Additionally, the famous actor from the most famous show in the world, who was deemed to have a cause of death relating to ketamine, isn't exactly helping mass adoption. Overall, this just makes marketing and advertising even more expensive, because a) the majority of referring providers are skeptical, b) patients can't pay for it and c) patients who can pay for it are cautious.Disruptive Business ModelsIn the model I've described above, there are 3 sets of cost centers: rent, staff, and marketing. In some areas of the country, rent may be negligible, and in others, it is quite high. Like an owner-operated restaurant, if a clinic is owned by a company that is not a clinician, they have to find one and pay for one. Venture-backed companies like Mindbloom, Better U, and Joyous have also created entire businesses on the back of the COVID-era controlled substance waivers, whereby they send patients ketamine tablets and/or lozenges directly through the mail. Unlike the clinic model, they don't have rent to pay, and since national marketing campaigns are often cheaper than hyper-local brick and mortar campaigns, they are able to find new patients at lower acquisition costs compared to their clinic counterparts. Some patients do extensive research before treatment and only want to find IV clinics that offer specific dosages, but many are fine with the cheapest ketamine possible, and would prefer to pay as low as $150 for an entire month compared to $3,000.Figure 3. Did you sign up for a discounted ketamine subscription on Black Friday after purchasing a new flat-screen TV?Spravato: Coming In HotJohnson & Johnson's branded esketamine (note the prefix es) is on track to reach coveted “blockbuster status.” While it was FDA approved for Major Depressive Disorder in 2019, it took some time to catch on for a number of reasons including skepticism that the added es only added to pharma pockets and didn't actually work, health insurance companies taking time to decide on what their medical necessity criteria should be, and social isolation due to COVID-19 being a thing. My clinic has become one of the larger Spravato providers in the Los Angeles area, and while we still offer ketamine infusions, our infusion census has decreased by over 70%. The scenario is this: a patient with severe depression comes in to see us, they've heard about ketamine, but they find out that Spravato is covered by insurance for a $20 copay. Maybe ketamine has slightly better efficacy (which, in my opinion, is really just a function of being able to adjust dosage). Still, patients would prefer paying a lot less money to receive almost-the-same benefits.Death By A Thousand SticksThere are a number of other issues with the model that become problematic, especially at scale. Large medical distributors like McKesson and Henry Shein have instituted CYA policies, limiting ketamine sales to licensed anesthesiologists. Medical malpractice carriers alike have followed suit, requesting detailed addendums from providers regarding their ketamine training or flat-out refusing coverage for anyone who isn't an anesthesiologist. Since controlled substance manufacturing is directed by the DEA based on their own predictions, it's not uncommon for ketamine to go on shortage for weeks to months at a time. There are a myriad of problems with the model of point solutions which have been detailed here already, but in short, the old adage rings true: if all you have is a hammer, everything looks like a nail, and if all you have is ketamine, everything looks like a juicy vein. But while ketamine is a highly efficacious treatment, it's not the best treatment for everyone, and patients can become downright dysregulated after ketamine, which a clinic in this model just can't handle adequately at scale. And ultimately, methods to do everything cheaper don't work out that well. For example, putting multiple patients in one room may seem like a good idea, but it is ultimately not conducive to the actual ketamine experience. Any sort of vertical integration also adds an insurmountable amount of complexity, like starting to offer Spravato or TMS, because now they have to start accepting insurance, become in-network, manage billing and AR, and so on. Depending on location and the clinic set-up, they also require specialized providers onsite.Figure 4. Supply chain issues abound.Insurance IssuesSome patients try to be well-informed. They, rightly or otherwise, don't believe everything they hear from their providers, so they call up their health insurance companies and ask. They just call the phone number on the back of the card and ask the representative if ketamine infusions are covered. Undoubtedly, the representative says yes—even though many insurance companies have published guidelines that explicitly deny any coverage for ketamine for a mental health disorder. These patients come in frustrated, distrustful of their providers and reaffirms their belief that ketamine clinics are just cash grabs. Even if one manages to obtain a coveted insurance contract for ketamine, like Ketamine Wellness Centers had with the VA, it kickstarts cashflow and complexity issues that scale should sort out, but ultimately doesn't because of the aforementioned issues above.Overall, it is possible to have a successful ketamine clinic in 2024. Still, it isn't easy due to market conditions, the population served, and the ever-changing landscape of mental health treatment. While many successful clinics exist today, the wheels tend to start to fall off when scaling, where all of a sudden, a clinic's reach has surpassed its captive population. Otherwise, it becomes a series of continual cost-cutting until there is nothing left to cut… save for the business itself.Ben Spielberg is the Founder and Chief Executive Officer of Bespoke Treatment, a comprehensive mental health facility with offices in Los Angeles, CA, and Las Vegas, NV. He is also a PhD Candidate in Cognitive Neuroscience at Maastricht University.For more on psychiatric medications, buy my book Inessential Pharmacology. (amazon link).For pieces by other TFP contributors, follow:Alex Mendelsohn, Michelle Bernabe, RN, @Psych Fox, Carlene MacMillan, MD, David Carreon, M.D., Benjamin Lippmann, DO, Awais Aftab, Courtny Hopen BSN, HNB-BC, CRRN, Leon Macfayden and many others! The Frontier Psychiatrists is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thefrontierpsychiatrists.substack.com/subscribe

In this episode, host Ellen Wong invites Steve Rio, the Co-founder of Enfold, to talk about the nature of the 5-MeO-DMT experience. Ellen shares about her experience at Enfold this April.About Mum's GuestSteve Rio is the Co-Founder of Enfold. He's a transformational performance coach, psychedelic guide, spiritual teacher, musician, entrepreneur and investor. His life's work focuses on raising consciousness and helping people realize their full potential. Steve sits on the board of TheraPsil, is an advisor to Numinus, Holos Global, and Nikean Foundation.Steve's Links* Enfold website: https://enfold.org* Enfold on Instagram: https://instagram.com/enfoldinstitute* Steve on Instagram: https://instagram.com/steverioAbout MUMWe are on Youtube! Subscribe to our channel.MUM is produced by ⁠Ellen Wong⁠ and edited by ⁠Stepfanie Aguilar.⁠ Your support allows us to continue creating this podcast. If you enjoy this episode, please take a moment to rate and review. Keep this conversation alive by bringing it to your communities.Follow Mum on Instagram ⁠⁠@mumthepod⁠⁠.If you are interested in working privately with Ellen, visit ⁠tripwithellen.com⁠ to learn more about her mentorship program and her spirit medicine programs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit tripwithellen.substack.com/subscribe

Send us a textIn this episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Gül Dölen MD, PhD. Gül is an associate professor of neuroscience at the Johns Hopkins University School of Medicine and a pioneer and world leader of psychedelics research. She earned her MD, PhD at Brown University and the Massachusetts Institute of Technology (MIT), where she carried out seminal work on critical periods, learning and memory, and the pathogenesis of autism. You can learn about her current work at dolenlab.org.In today's interview, Gul teaches us about critical learning periods and social reward learning. She clarifies what it really means when we say psychedelics cause “neuroplasticity” and explains the difference between metaplasticity and hyperplasticity. We talk about the possibility that psychedelics are the “master key” that unlocks various kinds of critical periods and what that means for treating psychiatric, neurodevelopmental, and even motor dysfunction like that found in stroke patients. She provides a neuromechanistic explanation for the phenomenology of a psychedelic trip and makes a case for the critical importance of psychotherapy in combination with psychedelic use for people who are seeking healing or behavior change.*This episode originally aired 08/15/23Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textDoes using cannabis put you at a greater risk of developing schizophrenia? Is it safe to use psychedelic-assisted therapy for psychotic disorders? Is there a difference between the psychotic experience and the psychedelic experience?In today's episode of the Psychedelic Therapy Frontiers podcast we discuss these questions as we explore the fascinating topic of psychosis.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textDo psychedelics make people more empathic? Does coming off antidepressants before psychedelic therapy affect outcomes? Can MDMA change your personality? Can a psychedelic medicine without the “trip” still help with depression? In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss recent studies that seek to answer these questions and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textWe've spent a lot of time on this show talking about the potential mental health risks and benefits of experiences occasioned by psychedelic medicines. But how do scientists and clinicians know if and to what extent a psychedelic experience is helpful or harmful? Well, we measure it. In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss the various ways that scientists and clinicians measure the psychedelic experience and the mental health outcomes of such an experience. We review a few popular questionnaires, discuss brain imaging studies, explore the limitations of these measurement tools, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn today's episode of the Psychedelic Therapy Frontiers podcast, we discuss what narcissism is, the difference between narcissistic personality disorder and narcissistic traits, some theories on why narcissism develops, why we might want to have compassion for someone with narcissistic traits, therapies for narcissism, how to protect yourself if you find yourself in relationship with someone with narcissistic traits, whether or not psychedelics could be a remedy for narcissism, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textYou've probably been given the advice at some point in your life that you shouldn't care about what other people think of you. For some of you this might feel pretty easy. For others it's a challenge. And for some of you the threat of negative social judgment and embarrassment is absolutely terrifying. In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss social anxiety disorder. We talk about how this mental health condition is different than being shy, introverted, or nervous about public performance. We also explore social anxiety from an evolutionary perspective, how social anxiety disorder is treated with medication and therapy, new treatments currently being studied, the importance of both a bottom-up and top-down approach to treatment, the power of exposure, and much more.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textSometimes it seems like life is crumbling around you. Maybe something terrible has happened or the accumulation of stressors is just too much to bear. What do you do when life keeps giving you lemons and you're just sick of making lemonade? In today's episode of the Psychedelic Therapy Frontiers podcast, we discuss tools and strategies for navigating life at its most difficult.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textHave you ever wondered what happens at an ayahuasca retreat? How do you know if out-of-country retreat centers are safe? Why would anyone voluntarily drink a tea that makes them vomit? What benefits do people report experiencing after participating in an ayahuasca ceremony? What are the dangers of ayahuasca? In today's episode of the Psychedelic Therapy Frontiers podcast, we explore these questions and more with founder and CEO of the LaWayra Ayahuasca retreat center in Colombia, Sam Believ. Sam is also the host of the Ayahuasca Podcast where he interviews experts in the psychedelic field about the healing power of ayahuasca.  For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.https://sambeliev.com/https://ayahuascaincolombia.com/https://ayahuascapodcast.com/Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textDo you think anger is a negative emotion? Have you ever been told that you need to control your anger? What's the difference between healthy and unhealthy expressions of anger?  In today's episode of the Psychedelic Therapy Frontiers podcast we're exploring this often misunderstood emotion and the strategies for processing and expressing anger in a healthy, adaptive way.For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textWhat do mental healthcare practitioners think of psychedelics? Does combining MDMA and psilocybin/LDS have therapeutic potential? Can DMT enhance the practice of experienced meditators? What can we learn from recurring dreams? Can your ADHD medication cause psychosis? In today's episode of the Psychedelic Therapy Frontiers podcast we're exploring a wide range of new research on these topics and others.    For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textIn this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Christopher Bache, PhD. Chris is professor emeritus in the department of Philosophy and Religious Studies at Youngstown State University, adjunct faculty at the California Institute of Integral Studies, Emeritus Fellow at the Institute of Noetic Sciences, and on the Advisory Council of Grof Legacy Training. He's the author of several books, but the one that prompted this interview is LSD and the Mind of the Universe—an account of what Chris experienced and learned from 73 high-dose LSD journeys that he embarked on over the course of 20 years. In today's conversation they explore Chris's LSD session protocol, the difference between using psychedelics for cosmological exploration vs spiritual enlightenment or psychiatric healing, how Chris processed and integrated his very intense experiences, what he learned about reincarnation, evolution at the collective and individual levels, what humans need to do to survive mounting existential threats, what he means by “diamond luminosity” and “diamond soul”, and much more.*This episode originally aired 12/05/23You can learn more about Chris at his website: https://chrisbache.com/ Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trialsLearn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.comFollow us on Instagram:https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Send us a textHave you ever had someone really listen to you? What does that feel like when somebody gives you their undivided, compassionate, and validating attention? In today's episode of the Psychedelic Therapy Frontiers podcast we're exploring the concept of deep listening. We discuss the difference between deep listening and simply hearing, improving relationships by listening well, the specific skill set required for deep listening, how to listen to people you don't agree with, how to listen to yourself, and much more.  For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Binge eating disorder is the newest addition to the eating disorder diagnostic category in the DSM. In today's episode of the Psychedelic Therapy Frontiers podcast we're exploring this condition, including its etiology, how it's diagnosed, prevalence rates, recent research, available treatments, the potential of psychedelic treatments, and much more.  For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Is meditation dangerous? It might seem like a silly question. Many people would put meditation on the short list of practices that are essential for good mental and spiritual health. Indeed, we've recommended meditation many times on this show as a powerful tool to use in psychedelic-assisted therapy.In today's episode of the Psychedelic Therapy Frontiers podcast we're exploring the situations in which meditation could do more harm than good. We discuss different kinds of meditation, personal and contextual risk factors that could put the meditation practitioner in harm's way, ways to mitigate these risks, research on the potential harms of meditation, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Have you ever felt conflicted about something–like there was a war going on in your head between parts of you with different agendas? Do you ever get frustrated with yourself for behaving in self-defeating ways only to find yourself repeating that same behavior over and over again? Well you, my friend, might have a mind comprised of many different parts, each with their own origin story, attachments, aversions, duties, and burdens. In today's episode of the Psychedelic Therapy Frontiers podcast we're revisiting the concept of intrapsychic multiplicity or “parts” through the lens of Internal Family Systems therapy or IFS. We discuss the idea of internal parts found in other personality theories and psychotherapy modalities, flesh out the basics of IFS, explore how IFS can be used in psychedelic-assisted therapy, discuss what it's like to go through formal Level 1 IFS training, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Stephen Thayer, a clinical psychologist and lead trainer for psychedelic therapists at Numinus. Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-262-stephen-thayer-phd/?ref=278 Dr. Thayer shares his journey from military psychologist to psychedelic-assisted therapy specialist, discussing his personal experiences with ketamine and psilocybin. He explores the integration of psychedelics into therapy and coaching, highlighting the distinctions between these roles. Dr. Thayer emphasizes the importance of facilitator training and personal psychedelic experiences, making a compelling case for evidence-based psychedelic mental healthcare alongside ceremonial or spiritual contexts. Note: This conversation was recorded in May 2024, prior to the FDA's decision on Lykos Therapeutics' MDMA-assisted therapy clinical trial for PTSD. The recent FDA ruling, which requested additional studies, will impact some of the information discussed regarding MDMA's path to medical approval. However, we believe this episode remains valuable for its insights into the broader landscape of psychedelic therapy, practitioner training, and the ongoing evolution of the field. Enjoy! Dr. Steve Thayer, Ph.D. is a clinical psychologist who specializes in psychedelic-assisted therapy practice, training, and research. He began his career in the U.S. Air Force where he led mental health care teams, provided therapeutic and assessment services, and counseled military leadership about community mental health concerns. As an adjunct professor, Dr. Thayer has taught graduate and undergraduate courses in counseling skills, clinical psychology, and personality theory. He has served as the lead therapist on several psychedelic medicine clinical trials and currently consults for Compass Pathways as a mentor to the therapists working on their phase 3 trial of psilocybin for treatment-resistant depression. Dr. Thayer is the Lead Instructor for Numinus's psychedelic-assisted therapy certification program and co-hosts Numinus's podcast, Psychedelic Therapy Frontiers. Dr. Thayer has a private therapy and coaching practice where he helps people resolve the unconscious blocks keeping them from creating the happiness, wealth, freedom, and relationships they crave. Highlights: From military psychology to psychedelic therapy Personal explorations with ketamine and psilocybin Psychedelics for mental health and spiritual exploration Integrating psychedelics into therapy and coaching Motivation for entering the psychedelic industry Bringing psychedelic awareness to the unconscious mind The potential for harm in the psychedelic underground Principles of effective psychedelic facilitation Assessing personal readiness as a psychedelic facilitator Experiential MDMA training for therapists Balancing evidence-based and spiritual approaches Episode Sponsors: Apollo Neuro - Third Wave listeners get 15% off. Soltara Healing Center: Use code TW200 to receive $200 off your next retreat.

On Aug 9th the FDA rejected the new drug application by Lykos (formerly MAPS PBC) for MDMA-assisted therapy for PTSD. This is disappointing news for those of us who were excited about the promising study results and eager to add MDMA-assisted therapy to the menu of treatment options for those suffering with PTSD. We discuss what appears to have influenced the FDA's decision, the possible path forward for Lykos, how this ruling affects other companies trying to bring different psychedelic medicines to market, and much more.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Do you ever feel like the world is going crazy around you? War, political polarization, cultural clashes, exploitation, all fed to your brain through a steady stream of addictive social media posts. In today's episode of the Psychedelic Therapy Frontiers podcast, we're going to discuss this modern predicament and how one might maintain their sanity in this increasingly insane world we live in. Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers, the podcast, Dr. Steve Thayer and Dr. Reid Robison focus on preparing for, navigating, and integrating psychedelic experiences. It serves as a comprehensive resource for those seeking healing, transformation, or exploration with psychedelic tools and for facilitators. *This episode originally aired 1/30/24Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Can you change your personality? What even is a “personality” anyway? Is my boyfriend a narcissist? What's borderline personality disorder? We human beings are complex creatures with a drive to understand ourselves. In that quest to understand ourselves, we've noticed some patterns. In today's episode of the Psychedelic Therapy Frontiers podcast, we're going to discuss these patterns through the lens of personality theory. Expect to learn what the term personality means, how personality differs from temperament, whether or not personalities can change, advantages and disadvantages of certain personality types, what a personality disorder is, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by me, Dr. Steve Thayer, and my co-host, Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

There is a lot of exciting research going on right now in the world of psychedelic medicine. So much, in fact, that it can be difficult to keep track of it all. Where do you go for reliable information? How do you interpret results? How is it that studies with similar hypotheses can have contradictory findings? In today's episode of the Psychedelic Therapy Frontiers podcast, we're going to discuss these questions while we walk you through a few studies that Reid and I found interesting. Expect to learn what psilocybin does to the brain, how psychedelic experiences affect death anxiety, how the therapeutic relationship influences outcomes in psychedelic-assisted therapy, whether or not remembering a psychedelic experience has a connection to positive mental health outcomes, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Has there ever been a time when you didn't feel like yourself? Maybe somebody did or said something to you and you overreacted in a way that left you feeling embarrassed or confused? Well, today we're going to examine experiences like this through the lens of what Swiss psychotherapist, Carl Jung, called the shadow. You're listening to Psychedelic Therapy Frontiers–the podcast devoted to exploring the frontiers of psychedelic medicine and what it takes to cultivate a healthy mind, body, and spirit. Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison. In addition to explaining what the personal shadow is, Reid and Steve explore the function of the shadow, how shadow content reveals itself to the conscious mind, methods of doing shadow work, the importance of self-compassion and acceptance when doing this work, how psychedelics are used in shadow work, and much more.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison explore defense mechanisms. They discuss what defense mechanisms are, how they can be adaptive and/or maladaptive, the utility of understanding your defensive psychological patterns, the importance of a non-shaming interpretation of defense mechanisms, how to work with them in conventional and psychedelic-assisted therapy, and much more.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison explore a few of their favorite tools and concepts for promoting and maintaining good mental hygiene. They discuss Dr. Phil Stutz's book The Tools, top-down vs bottom-up strategies, psychological multiplicity, self-compassion, self-discipline, mindfulness, helpful metaphors, leaning into discomfort, the power of using the breath as a tool, how tools become traps, and much more.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison  talk about the recent FDA psychopharmacologic drugs advisory committee meeting that resulted in a majority vote against the approval of MDMA-assisted therapy for PTSD based on MAPS/Lykos study data. They discuss what the committee's concerns were, the Institute for Clinical and Economic Review's (ICER) criticisms of the studies, the challenges of conducting psychedelic clinical trials, functional unblinding, how research and rater bias affects study data, and much more.https://psychedelicalpha.com/news/exclusive-therapists-and-trialists-from-lykos-phase-3-mdma-assisted-therapy-studies-push-back-on-icers-critical-draft-reportLearn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Reid Robison is joined by Garyth Moxey. Garyth Moxey, a native of Canada based in Vancouver, is a leading figure in entheogen provision and harm reduction advocacy. Trained as a psychedelic therapist at the Synthesis Institute, he specializes in using Ibogaine for opiate addiction detoxification. Reid and Garyth discuss ibogaine and 5-MeO-DMT for treating addiction and other conditions, as well as many other conversations on psychedelics and his journey. https://www.innerrealmscenter.com/Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Reid Robison is joined by Austin Mao. Austin is a serial entrepreneur, author, poet, community builder, and keynote speaker, celebrated for blending science, spirituality, psychology, and shamanism into his work. As the visionary co-founder of Ceremonia, a legal non-profit spiritual sanctuary near Denver, Colorado, he has committed his career to guiding profound, transformative journeys with psilocybin and ayahuasca. https://www.ceremoniacircle.org/https://www.austinmao.com/ https://www.instagram.com/austinmao/https://www.instagram.com/ceremoniacircle/https://www.facebook.com/ceremoniacirclehttps://www.youtube.com/@ceremoniacircle Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

In today's episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison talk about how to integrate a challenging psychedelic experience. They discuss what the integration process typically entails, some recent research on integration, what can make a psychedelic experience challenging to integrate, how the preparation process affects the integration process, special tips for integrating challenging experiences, and much more.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/